Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies

Author:

Guedeney Paul12ORCID,Claessen Bimmer E.1,Mehran Roxana1ORCID,Kandzari David E.3ORCID,Aquino Melissa1,Davis Scott4,Tamis Luis5,Wang John C.6,Othman Islam7,Gigliotti Osvaldo S.8,Haghighat Amir9,Singh Sarabjeet10,Lopez Mario11,Giugliano Gregory12,Horwitz Phillip A.13,Sorrentino Sabato1,Underwood Paul14,Allocco Dominic14,Meredith Ian T.14,Batchelor Wayne15

Affiliation:

1. Center for Interventional Cardiovascular Research and Clinical Trials, Icahn School of Medicine at Mount Sinai; New York New York

2. Sorbonne Université, ACTION study Group, INSERM UMRS 1166; Institut de Cardiologie, hôpital Pitié Salpêtrière (AP-HP); Paris France

3. Piedmont Heart Institute; Atlanta Georgia

4. Baptist Hospital; Little Rock Arkansas

5. Research Physicians Network Alliance; Hollywood Florida

6. Medstar Union Memorial Hospital; Baltimore Maryland

7. North Carolina Heart and Vascular Research; Raleigh North Carolina

8. Seton Heart Institute; Austin Texas

9. Cardiovascular Institute of Northwest Florida; Panama City Florida

10. Central Cardiology Medical Clinic; Bakersfield California

11. Charlotte Heart and Vascular Institute; Port Charlotte Florida

12. Baystate Medical Center; Springfield Massachusetts

13. University of Iowa Carver College of Medicine; Iowa City Iowa

14. Boston Scientific Corporation; Marlborough Massachusetts

15. Tallahassee Memorial Healthcare; Tallahassee Florida

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Reference31 articles.

1. Percutaneous revascularization strategies in small-vessel disease;Puymirat;Ann Cardiol Angeiol (Paris),2014

2. Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: insights from 2-year DUTCH PEERS (TWENTE II) randomized trial;Heijden;Am Heart J,2016

3. Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial;Wöhrle;EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol.,2016

4. Performance of the resolute zotarolimus-eluting stent in small vessels;Caputo;Catheter Cardiovasc Interv Off J Soc Card Angiogr Interv,2014

5. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (clinical evaluation of the XIENCE V everolimus eluting coronary stent system) and COMPARE (second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) randomized trials;Claessen;JACC Cardiovasc Interv,2011

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3